Skip to main content
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2020 Nov 17;19(1):3. doi: 10.1038/s41579-020-00489-1

Towards a chlamydia vaccine

Grant Otto 1,✉
PMCID: PMC7670482  PMID: 33203989

Abstract

This study reports a mutant Clamydia muridarum strain that infects the gastrointestinal tract and protects against genital tract infection in mice.

Subject terms: Clinical microbiology, Phage biology


Chlamydia is the most common sexually transmitted bacterial infection in humans but is often asymptomatic. Left untreated, chlamydia infection can lead to serious complications, such as infertility, and thus vaccine development is a priority. Morrison et al. studied Chlamydia muridarum infection in mice, isolating a mutant C. muridarum strain (termed GIAM-1) that shows substantially reduced infection of the genital tract compared with that of the wild type. However, GIAM-1 efficiently infected the gastrointestinal tract, which induced robust humoral immunity against C. muridarum. Importantly, gastrointestinal tract infection with GIAM-1 protected mice against subsequent genital tract infection with wild-type C. muridarum. These results suggest that by manipulating tissue-tropism to obtain immunogenic bacterial strains that do not infect the genital tract, a live-attenuated vaccine for the human pathogen Chlamydia trachomatis might be obtainable.

References

Original article

  1. Morrison SG, et al. A genital infection-attenuated Chlamydia muridarum mutant infects the gastrointestinal tract and protects against genital tract challenge. mBio. 2020;11:e02770-20. doi: 10.1128/mBio.02770-20. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Nature Reviews. Microbiology are provided here courtesy of Nature Publishing Group

RESOURCES